申请人:Schering AG
公开号:US20030176391A1
公开(公告)日:2003-09-18
This invention relates to a quick-release tablet formulation with >99.19% pure fludara (high-purity fludara) as an active ingredient in a defined composition of residual contaminants.
本发明涉及一种速释片剂,其活性成分氟达拉(高纯度氟达拉)的纯度大于 99.19%,并含有规定的残留污染物成分。